• bitcoinBitcoin(BTC)$61,501.00-1.49%
  • ethereumEthereum(ETH)$1,742.98-0.97%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$576.46-0.23%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.96-1.31%
  • solanaSolana(SOL)$72.45-0.84%
  • tronTRON(TRX)$0.3098120.35%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.042.32%
  • HyperliquidHyperliquid(HYPE)$66.810.21%
  • zcashZcash(ZEC)$886.51-2.78%
  • moneroMonero(XMR)$493.09-1.68%
  • dogecoinDogecoin(DOGE)$0.057651-1.79%
  • leo-tokenLEO Token(LEO)$9.25-0.61%
  • whitebitWhiteBIT Coin(WBT)$59.69-1.33%
  • chainlinkChainlink(LINK)$8.88-1.81%
  • USDSUSDS(USDS)$1.00-0.16%
  • cardanoCardano(ADA)$0.150517-0.58%
  • Ethena USDeEthena USDe(USDE)$1.000.02%
  • stellarStellar(XLM)$0.131594-4.37%
  • daiDai(DAI)$1.000.00%
  • nearNEAR Protocol(NEAR)$3.21-1.86%
  • bitcoin-cashBitcoin Cash(BCH)$204.97-0.94%
  • litecoinLitecoin(LTC)$41.86-4.66%
  • CantonCanton(CC)$0.079881-2.29%
  • RainRain(RAIN)$0.004479-4.43%
  • avalanche-2Avalanche(AVAX)$6.90-1.24%
  • uniswapUniswap(UNI)$4.94-4.31%
  • tether-goldTether Gold(XAUT)$3,637.48-2.24%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.020.16%
  • suiSui(SUI)$0.70-2.49%
  • USD1USD1(USD1)$1.000.03%
  • Ripple USDRipple USD(RLUSD)$1.00-0.04%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.14%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.04%
  • hedera-hashgraphHedera(HBAR)$0.053285-4.24%
  • BittensorBittensor(TAO)$191.430.18%
  • shiba-inuShiba Inu(SHIB)$0.000004-0.76%
  • quant-networkQuant(QNT)$149.21-0.79%
  • crypto-com-chainCronos(CRO)$0.041077-3.87%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.01%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • MemeCoreMemeCore(M)$0.83-6.33%
  • okbOKB(OKB)$85.38-1.35%
  • Falcon USDFalcon USD(USDF)$1.000.05%
  • United StablesUnited Stables(U)$1.000.05%
  • pax-goldPAX Gold(PAXG)$3,636.51-2.27%
  • aaveAave(AAVE)$103.84-3.70%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Psychedelic therapy for stressed workers gains traction at firms

August 9, 2023
in Business
Reading Time: 10 mins read
A A
Psychedelic therapy for stressed workers gains traction at firms
ShareShareShareShareShare

American companies are increasingly offering psychedelic therapy as a workplace benefit for employees seeking alternative treatments to conditions such as post-traumatic stress disorder, anxiety and depression, according to a report.

Enthea, a startup that offers third-party administrative services for health insurance plans, told Fast Company that it has enrolled some 50 firms to begin offering the perk to its workers.

YOU MAY ALSO LIKE

Walmart warns of fuel cost pressure, lifts sales forecast ahead of holidays

TJ Maxx closes California stores, lays off 139 employees

One of those companies, Dr. Bonner’s, which makes natural soap, offered around 7% of its 320 employees access to alternative therapy through the use of ketamine, a tranquilizer that has hallucinogenic qualities and is usually prescribed by veterinarians.

An anonymous survey found that of those 7% who were treated with ketamine, a whopping 86% showed improvement in their symptoms of post-traumatic stress disorder while 67% reported a reduction in symptoms of depression-related illnesses.

Some 65% of those who took part in the survey said they noticed a decline in symptoms of generalized anxiety disorder.


Lawmakers in several states have proposed decriminalizing psychedelics to advance the treatment of conditions such as depression and anxiety.
AFP via Getty Images

The introduction of psychedelic drugs for medicinal and therapeutic purposes has gained momentum in tech circle in recent years.

Earlier this year, X owner Elon Musk acknowledged that he used ketamine in microdoses to help him treat depression.

Witnesses told The Wall Street Journal that they observed Musk ingest the popular club drug known as Special K at parties.

Musk’s good friend and fellow tech mogul, Google co-founder Sergey Brin, has also reportedly been known to take magic mushrooms, also known as psilocybin.


At least 50 American companies are offering psychedelic therapy as a workplace benefit for employees seeking alternative treatments to conditions such as post-traumatic stress disorder, anxiety.
At least 50 American companies are offering psychedelic therapy, including ketamine (above), as a workplace benefit for employees seeking alternative treatments to conditions such as PTSD and anxiety.
AFP via Getty Images

Studies conducted by researchers at Johns Hopkins Medicine and other institutions have shown that patients diagnosed with depression and other mental health disorders reported improvements in their symptoms.

Clinical trials have also shown that psychedelics are just as effective — if not more so — than traditional medications used to treat depression and anxiety.

A series of studies from Johns Hopkins University’s psychedelics research unit found that magic mushroom-assisted therapy can reduce depression symptoms for up to a year and be effective for individuals for whom other treatments haven’t worked.

The promising results have prompted lawmakers in several states to advocate for decriminalization of magic mushrooms or at least making them legal for medical use.


The use of psilocybin, also known as magic mushrooms, to treat mental health disorders has become mainstream in recent years.
The use of psilocybin, also known as magic mushrooms, to treat mental health disorders has become mainstream in recent years.
AFP via Getty Images

Legislation to allow research on the therapeutic benefits psilocybin is under consideration in states across the political spectrum this year, including in Arizona, Hawaii and Oklahoma.

Legislation to legalize therapeutic use or create pilot programs is under consideration in states including California, Connecticut, New York, Utah, and Washington.

In Virginia, two magic mushroom-related bills failed to advance this year in the politically divided General Assembly.

With Post Wires

Credit: Source link

ShareTweetSendSharePin

Related Posts

Walmart warns of fuel cost pressure, lifts sales forecast ahead of holidays
Business

Walmart warns of fuel cost pressure, lifts sales forecast ahead of holidays

November 19, 2026
TJ Maxx closes California stores, lays off 139 employees
Business

TJ Maxx closes California stores, lays off 139 employees

November 19, 2026
7B isn’t enough? Anthropic CEO eyes debt binge just hours after blockbuster IPO
Business

$107B isn’t enough? Anthropic CEO eyes debt binge just hours after blockbuster IPO

November 19, 2026
Amazon warns NYC customers they face price hikes up to  for every order if delivery bill is passed
Business

Amazon warns NYC customers they face price hikes up to $5 for every order if delivery bill is passed

November 19, 2026
Next Post
U.S. House Approves .1 Trillion Bill to Finance Government – TheStreet

U.S. House Approves $1.1 Trillion Bill to Finance Government - TheStreet

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Russia strikes Kyiv hours after talks with U.S.

Russia strikes Kyiv hours after talks with U.S.

November 18, 2026
Most Tax Moves Are Due December 31 – IRA & HSA Contributions Can Wait

Most Tax Moves Are Due December 31 – IRA & HSA Contributions Can Wait

November 18, 2026
Google Wallet Is Launching On iOS

Google Wallet Is Launching On iOS

November 17, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!